'One Test, Eleven Answers' targets genetic diseases
About one in five Ashkenazi Jews is a carrier of one of 11 life-threatening diseases for which screening tests are now available. That's the message of a new screening education campaign called "One Test, Eleven Answers" launched recently by the Genetic Disease Foundation (GDF).
About one in five Ashkenazi Jews is a carrier of one of 11 life-threatening diseases for which screening tests are now available. That's the message of a new screening education campaign called "One Test, Eleven Answers" launched recently by the Genetic Disease Foundation (GDF).
The campaign, aimed at couples in which one or both members is of Jewish descent, explains that only one blood sample is necessary from each individual to perform all 11 tests. The diseases that can be identified prior to or early in pregnancy are Bloom Syndrome, Canavan Disease, Cystic Fibrosis, Familial Dysautonomia, Fanconi Anemia Type C, Gaucher Disease, Glycogen Storage Disease Type 1A, Maple Syrup Urine Disease, Mucolipidosis IV, Type A Niemann-Pick Disease, and Tay-Sachs Disease.
The GDF, a non-profit organization established in 1997 by patients, parents, and families, is dedicated to the research, treatment, and cure of all genetic diseases. For more information, call 212-659-6704 or log on to http://www.geneticdisease.org/.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
